Harmony Biosciences Valuation
| HRMY Stock | USD 33.23 0.44 1.34% |
At this time, the firm appears to be undervalued. Harmony Biosciences retains a regular Real Value of $38.95 per share. The prevalent price of the firm is $33.23. Our model calculates the value of Harmony Biosciences from evaluating the firm fundamentals such as Return On Equity of 0.23, current valuation of 1.64 B, and Return On Asset of 0.13 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Harmony Biosciences' valuation include:
Price Book 3.1335 | Enterprise Value 1.6 B | Enterprise Value Ebitda 7.5448 | Price Sales 2.7425 | Forward PE 8.0841 |
Undervalued
Today
Please note that Harmony Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Harmony Biosciences is based on 3 months time horizon. Increasing Harmony Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Harmony Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Harmony Stock. However, Harmony Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.23 | Real 38.95 | Target 42.89 | Hype 33.2 | Naive 30.98 |
The intrinsic value of Harmony Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Harmony Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Harmony Biosciences Holdings helps investors to forecast how Harmony stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Harmony Biosciences more accurately as focusing exclusively on Harmony Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Harmony Biosciences' intrinsic value based on its ongoing forecasts of Harmony Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Harmony Biosciences' closest peers.
Harmony Biosciences Cash |
|
Harmony Valuation Trend
Analysing the historical paterns of Harmony Biosciences' enterprise value and its market capitalization is a good way to estimate and gauge the value of Harmony Biosciences Holdings over time and is usually enough for investors to make rational market timing decisions.
Harmony Biosciences Total Value Analysis
Harmony Biosciences Holdings is currently expected to have valuation of 1.64 B with market capitalization of 1.87 B, debt of 193.57 M, and cash on hands of 254.17 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Harmony Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.64 B | 1.87 B | 193.57 M | 254.17 M |
Harmony Biosciences Investor Information
About 93.0% of the company shares are owned by institutional investors. The book value of Harmony Biosciences was currently reported as 10.47. The company has Price/Earnings (P/E) ratio of 293.37. Harmony Biosciences had not issued any dividends in recent years. Based on the key indicators related to Harmony Biosciences' liquidity, profitability, solvency, and operating efficiency, Harmony Biosciences Holdings is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December.Harmony Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Harmony Biosciences has an asset utilization ratio of 71.73 percent. This suggests that the Company is making $0.72 for each dollar of assets. An increasing asset utilization means that Harmony Biosciences Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Harmony Biosciences Ownership Allocation
Harmony Biosciences Holdings has a total of 57.03 Million outstanding shares. The majority of Harmony Biosciences outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Harmony Biosciences to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Harmony Biosciences Holdings. Please pay attention to any change in the institutional holdings of Harmony Biosciences as this could imply that something significant has changed or is about to change at the company. Also note that almost two million five hundred thirty-two thousand one hundred ninety invesors are currently shorting Harmony Biosciences expressing very little confidence in its future performance.Harmony Biosciences Profitability Analysis
The company reported the previous year's revenue of 582.02 M. Net Income was 128.85 M with profit before overhead, payroll, taxes, and interest of 354.37 M.About Harmony Biosciences Valuation
Our relative valuation model uses a comparative analysis of Harmony Biosciences. We calculate exposure to Harmony Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Harmony Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 460.8 M | 483.8 M | |
| Pretax Profit Margin | 0.30 | 0.31 | |
| Operating Profit Margin | 0.33 | 0.35 | |
| Net Profit Margin | 0.22 | 0.23 | |
| Gross Profit Margin | 0.79 | 0.64 |
Harmony Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 60.4 M | |
| Quarterly Earnings Growth Y O Y | 0.254 | |
| Forward Price Earnings | 8.0841 |
Harmony Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Harmony Biosciences Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Harmony we look at many different elements of the entity such as Harmony's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Harmony Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Harmony Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Harmony Biosciences' worth.Additional Tools for Harmony Stock Analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.